The role of local radiotherapy following rituximab‐containing chemotherapy in patients with transformed indolent B‐cell lymphoma

This study aimed to evaluate the outcomes of local radiotherapy (LRT) in patients with histologic transformation (HT) following rituximab‐containing chemotherapy.

[1]  Deborah A. Freedman-Cass,et al.  Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

[2]  J. Cerhan,et al.  Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Bingshu E. Chen,et al.  Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12. , 2015, Blood.

[4]  L. Gordon,et al.  Transformed non‐Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database , 2013, British journal of haematology.

[5]  J. Cerhan,et al.  Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Summer S. Han,et al.  Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. , 2013, Blood.

[7]  R. Gascoyne,et al.  Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[9]  Richard J. Jones,et al.  Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomas. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  K. Blum,et al.  High‐dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B‐cell lymphoma , 2008, European journal of haematology.

[11]  Randy D Gascoyne,et al.  Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  L. Rimsza,et al.  Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Advani,et al.  Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Rossi,et al.  Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  G. Salles,et al.  Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  H. Tilly,et al.  Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Horning,et al.  Long-term survival after histologic transformation of low-grade follicular lymphoma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.